Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Plendil

(Felodipine)

ApprovedSmall molecule

Plendil is one of 67 small molecule programs targeting Hypertension. It is currently in Approved.

4

Indications

11

Total Trials

0

Active Trials

66

Competitors

1

FDA Application

NDA/BLA/ANDA regulatory filings

Pipeline

Status by Indication[3][1]

Indication

HypertensionActive, not recruiting

Fasting ConditionsCompleted

FedCompleted

HypertensionApproved

Active, not recruiting

Fasting ConditionsPreclinical

Completed

FedPreclinical

Completed

Competition

Competitive Landscape

157 competitors in Hypertension

#DrugCompanyPhaseTrials

Foundayo

Baxfendy

Plendil

Nitrostat

VViatris Specialty LLC

Alka-Seltzer

HCP1803-3

Hanmi Pharmaceutical Company Limited

Avastin

Winrevair

Alphagan

Deltavit

HHyundai Pharmaceutical Co., LTD.

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Blood Pressure1 trial

The Effects on Blood Pressure Control, Pulse Wave Velocity, as Well as Safety and Tolerability of Felodipine Sustained Release in Chinese Patients.

Completed· AstraZeneca logo

AstraZeneca·N/A·NCT02336607·529 enrolled

Effectiveness1 trial

Candesartan Effectiveness Study in Pro-B Type Natriuretic Peptides (BNP)

Completed· AstraZeneca logo

AstraZeneca·Phase 4·NCT00348686·315 enrolled

Vasodilation1 trial

Role of AT1-receptor Blockers in Insulin-induced Vasodilation.

Unknown status·MMaastricht University Medical Center·N/A·NCT00742066·32 enrolled

AIN1 trial

Felodipine Controlled Release Tablets and Felodipine Sustained Release Tablets in Healthy Subjects Under Fasting State Comparative Pharmacokinetic Study

Unknown status·OOverseas Pharmaceuticals, Ltd.·Phase 1·NCT05614037·16 enrolled

Hypertension1 trial

Compare the Effects of Lercanidipine Hydrochloride Tablet (Zanidip®) and Felodipine Sustained-Release Tablet for Hypertension

Completed·LLee's Pharmaceutical Limited·Phase 4·NCT01520285·281 enrolled

6 more indications

Fasting Conditions1 trial

Bioequivalence Study of Felodipine ER Tablets 10 mg Under Fasting Conditions

Completed·RRanbaxy Laboratories Limited·N/A·NCT02327247·48 enrolled

Complication1 trial

Copenhagen Acute Renal Complications After Transplantations Study Group

Completed·RRigshospitalet, Denmark·Phase 4·NCT02744872·42 enrolled

Interaction1 trial

Evaluation of the Pharmacokinetic Interaction Between Candesartan and Felodipine After Ingestion of a Specific Meal

Completed· AstraZeneca logo

AstraZeneca·Phase 1·NCT00905333·36 enrolled

Fed1 trial

Bioequivalence Study of Felodipine ER Tablets 10 mg Under Fed Conditions

Completed·RRanbaxy Laboratories Limited·N/A·NCT02311530·80 enrolled

Hypertensive1 trial

Coffee Interaction With the Antihypertensive Drug Felodipine

Completed·LLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's·Phase 1·NCT02232269·13 enrolled

Unspecified1 trial

Felodipine Event Reduction Study

Completed·CChinese Academy of Medical Sciences·N/A·NCT01136863·9,800 enrolled

Regulatory

FDA Approval Timeline[4]

Sep 22, 1994

PLENDIL

NDA NDA019834

Sources

References

[1]
ClinicalTrials.gov — 11 trial records for Felodipine. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Felodipine compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Felodipine. EMBL-EBI & Wellcome Sanger Institute.
[4]
OpenFDA — FDA approval records (NDA NDA019834). U.S. Food & Drug Administration.
[5]
SEC EDGAR — AstraZeneca company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Approved[1]
Company: AstraZeneca

Related News